MARKET

RVNC

RVNC

Revance Therapeu
NASDAQ
2.710
+0.040
+1.50%
After Hours: 2.780 +0.07 +2.58% 19:19 05/24 EDT
OPEN
2.700
PREV CLOSE
2.670
HIGH
2.760
LOW
2.630
VOLUME
1.52M
TURNOVER
0
52 WEEK HIGH
33.10
52 WEEK LOW
2.625
MARKET CAP
283.06M
P/E (TTM)
-0.7418
1D
5D
1M
3M
1Y
5Y
Revance Therapeutics (RVNC) Loses -18.85% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
NASDAQ · 1d ago
Weekly Report: what happened at RVNC last week (0513-0517)?
Weekly Report · 5d ago
Revance Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 05/13 16:47
Revance Therapeutics Price Target Cut to $11.00/Share From $12.00 by HC Wainwright & Co.
Dow Jones · 05/13 16:47
HC Wainwright & Co. Maintains Buy on Revance Therapeutics, Lowers Price Target to $11
Benzinga · 05/13 16:37
Revance Therapeutics Is Maintained at Neutral by Goldman Sachs
Dow Jones · 05/13 16:03
Revance Therapeutics Price Target Cut to $8.00/Share From $9.00 by Goldman Sachs
Dow Jones · 05/13 16:03
Goldman Sachs Maintains Neutral on Revance Therapeutics, Lowers Price Target to $8
Benzinga · 05/13 15:52
More
About RVNC
Revance Therapeutics, Inc. is a biotechnology company focused on developing and commercializing aesthetic and therapeutic offerings. The Company's portfolio includes DAXXIFY (DaxibotulinumtoxinA-lanm) for injection and the RHA Collection of dermal fillers in the United States. It has also partnered with Viatris to develop a biosimilar to onabotulinumtoxinA for injection and Fosun to commercialize DAXXIFY in China. Its product/product candidate includes DAXXIFY for glabellar lines indication; DAXXIFY for cervical dystonia indication; RHA Redensity for perioral rhytids indication; RHA 2/ RHA 3/ RHA 4 for facial wrinkles and folds (such as nasolabial folds) indication; DAXXIFY for forehead lines, lateral canthal lines, upper facial lines indication; DAXXIFY for upper limb spasticity indication, and onabotulinumtoxinA biosimilar. The Company has exclusive right to import, market, promote, sell and distribute Teoxane's line of Resilient Hyaluronic Acid dermal fillers.

Webull offers Revance Therapeutics Inc stock information, including NASDAQ: RVNC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVNC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVNC stock methods without spending real money on the virtual paper trading platform.